Ditan Decoction ameliorates vascular dementia-induced cognitive dysfunction through anti-ferroptosis via the HIF1α pathway: Integrating network pharmacology and experimental validation
Journal of Ethnopharmacology · 2025-03 · 344 · 119459
DOI: 10.1016/j.jep.2025.119459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025-03. Verfasst von Mengyu Gu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hubei University of Chinese Medicine, Wuhan, 430065, China; Department of Gerontology, Hubei Provincial Hospital of Integrated Chinese and Western Me…. Hauptthemen laut MEDLINE: Dementia, Vascular, Hypoxia-Inducible Factor 1, alpha Subunit, Cognitive Dysfunction, Drugs, Chinese Herbal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Vascular dementia (VaD) represents a frequently seen cognitive dysfunction syndrome and has ranks second among dementia subtypes following Alzheimer's disease. At present, Ditan Decoction (DTD), the traditional Chinese herbal prescription, is clinically applied in treating VaD. However, the material basis of its efficacy and therapeutic mechanism still remain unknown. AIM OF THE STUDY: This experiment investigated the protection induced by DTD against VaD and the associated mechanism through network pharmacology, mass spectrometry analysis, and in vivo validation. MATERIALS AND METHODS: We induced VaD in a rat model using bilateral common carotid artery ligation method (2-VO) and administered DTD at doses of 2.14, 4.28 and 8.55 g/kg, with Memantine (0.9 mg/kg) being the positive control. Following oral administration with DTD or Memantine for 4 weeks, behavioral tests were used for assessing cognitive function. H&E and Nissl staining was used for evaluating hippocampal pathology. TEM was used to visualize the ultrastructure of the hippocampal tissue. ELISA was carried out for measuring inflammatory factor levels in rat serum, and biochemical assays were employed to assess oxidative stress levels. Ferroptosis in the hippocampus was examined through analyzing corresponding biomarkers and protein expression. Additionally, HPLC-Q-Exactive-MS technology was employed for identifying DTD components, whereas network pharmacology was conducted for predicting DTD's targets for treating VaD. HIF1α expression levels were assessed by Western blotting and immunofluorescence. We also further validated whether the protective effects of DTD on VaD were mediated through the HIF1α-regulated ferroptosis signaling pathway by using an HIF1α inhibitor in rats. RESULTS: DTD demonstrated protective effects against 2VO-induced hippocampal injury through alleviating oxidative stress, lowering systemic inflammation, while preventing ferroptosis of hippocampal tissue. As revealed by network pharmacology, DTD probably executes its function in VaD by activating HIF1α pathway. According to immunofluorescence and Western blotting, DTD activated HIF1α within hippocampal tissue. Furthermore, DTD's protection against VaD and ferroptosis was reversed when an HIF1α inhibitor was applied. CONCLUSION: These findings suggested that DTD rescued cognitive dysfunction in VaD by inhibiting ferroptosis via activating HIF1α pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei University of Chinese Medicine, Wuhan, 430065, China; Department of Gerontology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, 430022, China.
- Hubei Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430061, China; Hubei Shizhen Laboratory, Wuhan, 430065, China.
- Department of Gerontology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, 430022, China.
- Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Electronic address: 360236862@qq.com.
- Department of Gerontology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, 430022, China. Electronic address: yc250820883@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gu, M., Sun, L., Yang, J., Wang, K., Wu, F., Zheng, L., Shen, X., Lai, X., Gong, L., Peng, Y., Xu, S., Yang, J., & Yang, C. (2025). Ditan Decoction ameliorates vascular dementia-induced cognitive dysfunction through anti-ferroptosis via the HIF1α pathway: Integrating network pharmacology and experimental validation. Journal of Ethnopharmacology, 344, 119459. https://doi.org/10.1016/j.jep.2025.119459
Vancouver
Gu M, Sun L, Yang J, Wang K, Wu F, Zheng L, et al. Ditan Decoction ameliorates vascular dementia-induced cognitive dysfunction through anti-ferroptosis via the HIF1α pathway: Integrating network pharmacology and experimental validation. Journal of Ethnopharmacology. 2025;344:119459. doi:10.1016/j.jep.2025.119459
BibTeX
@article{Gu2025,
author = {Gu, Mengyu and Sun, Lieqian and Yang, Jie and Wang, Kaiyi and Wu, Fan and Zheng, Li and Shen, Xiangzhong and Lai, Xing and Gong, Lili and Peng, Ying and Xu, Shujie and Yang, Jia and Yang, Chao},
title = {Ditan Decoction ameliorates vascular dementia-induced cognitive dysfunction through anti-ferroptosis via the HIF1α pathway: Integrating network pharmacology and experimental validation},
journal = {Journal of Ethnopharmacology},
year = {2025},
volume = {344},
pages = {119459},
doi = {10.1016/j.jep.2025.119459}
}
EUVIMED